Investment grade issuers front-load $52bn of supply ahead of the balance sheet decision

Corporate treasurers cannot forecast a balance sheet decision, so they scheduled around it instead. Thirty-seven deals priced $52.0bn of supply in the six sessions from September 1, against a dealer consensus of $34bn and a run rate through the second half of August that never cleared $8bn in a week. Three syndicate desks put a third or more of the total as volume pulled forward from October. The reason offered in every conversation was the same one: nobody wants to be marketing a thirty-year tranche the morning after policymakers change what they do with maturing proceeds.

The reception split cleanly by rating. High grade borrowers paid almost nothing for going early: single-A paper cleared 4 basis points above where the issuer's curve was marked at launch, triple-B at 7, and the larger books were covered better than three times. Loxley Pharmaceutical Group took $4.5bn across four tranches with a two basis point concession, the tightest print of the year at that size.

Below investment grade the arithmetic inverts. Five double-B deals cleared at an average concession of 27 basis points, six single-B deals at 44, and of the three triple-C attempts one was withdrawn after two days of marketing. That is a market that will fund the borrowers who do not need the money and negotiate hard with the ones who do, which is the normal condition of a credit cycle in its later stages rather than a sign of stress.

A $38bn partial week is the largest three session total since March 2024. The cost of that concentration shows up later in the month. Dealers carry inventory from every deal they underwrite, and the usual way inventory clears is into the next week's new issue demand. Empty the calendar and the inventory sits, which is one reason secondary spreads on recently priced paper have drifted 6 to 9 basis points wider since Thursday even as the primary market looked healthy.

Everyone wanted to be done before Wednesday. Being done before Wednesday means the desk owns the paper on Thursday, and on Thursday there is no calendar to sell it into.

Cedric Balfour, head of debt syndicate at Harrow Lane Capital

• High grade net supply for September now runs roughly $19bn ahead of the same point last year, almost entirely because of the pull forward rather than an increase in full year funding needs.
• Maturities falling due in the fourth quarter total $61bn across the high grade index, so the refinancing that was the stated reason for most of these trades is genuine rather than opportunistic.
• Sterling and euro denominated issuance by US borrowers has doubled month on month, which is a direct response to hedged funding costs rather than a view on any domestic curve.
• Two issuers that had mandated banks for thirty-year tranches cut them to ten-year maximum maturity during marketing, which is the clearest single signal of where the demand ends.

The thirty-year tranche withdrawals matter more than the headline number. Long corporate paper is bought by insurers and pension funds matching liabilities, and that buyer base has spent the past three months asking for more compensation on every asset with duration attached. Two mandates cut back to a ten-year maximum during marketing is a small sample. It is also the first time this year that any borrower has shortened a deal for lack of demand rather than for pricing.

The rest of the month is close to empty by design, which makes the week of September 21 the next real test. The borrowers who did not move forward will meet a market that has by then absorbed a thirty-year auction, a services inflation print and whatever the reinvestment decision does to the long end.